The Outpatient Continuity Clinics at the Jacqueline Maritz Lung Center, located in the Center for Advanced Medicine, is staffed by attending physicians and fellows from the Division of Pulmonary and Critical Care Medicine. More than 1,700 new patients and more than 10,000 return patients were seen in the Lung Center in fiscal year 2020. There are frequently internal medicine residents and medical students present in clinic as well. The pulmonary function laboratory is conveniently located across the hall from the Lung Center.
General pulmonary clinics
There are multiple clinics weekly focused on general pulmonary referrals and longitudinal follow-up and care for patients with both acute and chronic lung diseases.
Cystic fibrosis clinic
The care in the Cystic Fibrosis Clinic is provided by a multidisciplinary team including attending physicians, fellows, nurse coordinators, dieticians, and social workers. Once or twice each month, Marina Litvin, MD, from the Division of Endocrinology is also present in clinic to see and co-manage patients with diabetes or other endocrine-related complications of cystic fibrosis.
Additionally, as a Cystic Fibrosis Foundation Therapeutics Development Center, the Cystic Fibrosis Clinic hosts a robust clinical trials program.
Lung transplant clinics
Dedicated lung transplant clinics are held at the Jacqueline Maritz Lung Center on Monday, Tuesday, and Wednesday. A multidisciplinary team of lung transplant specialists including pulmonologists, nurse coordinators, and pharmacists staffs these clinics. Pulmonary and critical care fellows rotate in these transplant clinics as part of their longitudinal outpatient training.
The Pre-Transplant Clinic focuses on the evaluation and management of new referrals for lung transplantation and the longitudinal care of patients with advanced lung disease who are listed and waiting or are being considered for transplantation. The Post-Transplant Clinic provides comprehensive longitudinal management for lung transplant recipients.
Pulmonary vascular disease clinics
The Pulmonary Vascular Clinics are the outpatient arm of the Washington University School of Medicine/Barnes-Jewish Hospital’s Pulmonary Hypertension Care Center and the Washington University Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence.
The clinics operate in the Center for Advanced Medicine on the Washington University Medical Center campus at the Heart Vascular Center on the Barnes-Jewish West County campus, and at the Center for Advanced Medicine’s South County location.
Patients are referred from throughout the region and our staff strive to collaborate with local health-care providers to co-manage patients with pulmonary hypertension and HHT. Initial consultation includes comprehensive same-day testing in the Pulmonary Function Lab and Cardiac Diagnostics Lab and other critical areas of the medical center in a carefully coordinated fashion.
Interstitial lung disease clinic
Under the direction of Tonya Russell, MD, and Adrian Shifren, MD, the Interstitial Lung Disease (ILD) Clinic focuses on patients with ILD such as idiopathic pulmonary fibrosis, autoimmune related ILD, chronic hypersensitivity pneumonitis, and other rare interstitial lung diseases. Services include diagnostic evaluation, short- and long-term medical management, and monitoring of immunosuppression and immunomodulatory therapy. All new referrals to the ILD Clinic are presented and discussed at a weekly, multidisciplinary ILD conference involving physicians from pulmonary, radiology, pathology, and often rheumatology. The ILD Clinic is continuously participating in clinic trials for treatment of ILD.
Washington University School of Medicine in St. Louis/Barnes-Jewish Hospital is a certified Pulmonary Fibrosis Foundation Care Network site. Our site provides the medical expertise required to assist patient with pulmonary fibrosis to fully manage their disease. We offer a multidisciplinary approach that delivers comprehensive patient care. Our expert faculty includes specialists in pulmonary medicine, rheumatology, radiology, and pathology, all specializing in interstitial lung disease. We are also a Lymphangioleiomyomatosis (LAM) Foundation-Approved LAM Clinic. In partnership with the Histiocytosis Association, the LAM Clinic is interested in improving the care and treatment of patients with LAM, pulmonary Langerhans cell histioctyosis, and other rare lung diseases.
Severe asthma clinic
Under the direction of Kaharu Sumino, MD, MPH, the Severe Asthma Clinic focuses on patients with severe asthma that is not responding to conventional therapies. In addition to treatment with newer biologic agents, patients are evaluated for candidacy for bronchial thermoplasty.
The Severe Asthma Clinic actively participates in clinical trials and research projects targeted at understanding the disease process and treatment of patients with severe asthma.
The Severe Asthma Clinic refers patients to our NIH funded studies in the Severe Asthma Research Program (SARP), AsthmaNet, and Xenon MRI guided Bronchial Thermoplasty, and our American Lung Association Airways Clinical Research Center (ACRC) studies. In addition, patients with severe asthma are evaluated for investigational therapies available through the Asthma and Airway Translational Research Unit.
Interventional pulmonary clinic
The Interventional Pulmonary (IP) clinic sees referrals for lung nodules or masses, lymphadenopathy, airway stenosis, and pleural disease. When indicated, patients are scheduled for procedures and followed longitudinally in IP clinic.
Our interventional pulmonary service enjoys a close collaborative working relationship with the oncology services at Siteman Cancer Center.
Under the direction of Adam Anderson, MD, the Washington University Sarcoidosis program is certified as a World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) Sarcoidosis Center of Excellence. While the pulmonary clinic addresses all organ manifestations and treatments for multisystemic sarcoidosis, the center has grown to include specialists within the pertinent specialties.
- Pulmonary: Adam Anderson, MD and Daniel Reynolds, MD
- Rheumatology: Deborah Parks, MD and Michael Paley, MD, PhD
- Neurology: David Clifford, MD and S. Richard Dunham, MD
- Dermatology: Muithi Mwanthi, MD, PhD
- Ophthalmology: Lynn Hassman, MD, PhD
- Hepatology: Kevin Korenblat, MD
- Heart Failure: Justin Vader, MD
- Electrophysiology: Marye Gleva, MD
- Nephrology: Anitha Vijayan, MD
- Endocrinology/Bone Health: Naga Yalla, MD
Pulmonary mycobacterial disease and bronchiectasis clinic
Under the direction of Dr. Shail Mehta (Pulmonology), Dr. Carlos Mejia, and Dr. Thomas Bailey (Infectious Diseases), the multidisciplinary pulmonary nontuberculous mycobacterial (NTM) clinic sees all patients with pulmonary NTM disease. The clinic utilizes an integrated approach (pulmonology, infectious disease and thoracic surgery) for patients with suspected, new, or refractory disease. Clinical trials are available for patients in whom standard therapies have not been effective. Patients can also participate in other basic scientific studies.
Dr. Mehta also directs the bronchiectasis clinic. This clinic sees and treats patients with bronchiectasis who often suffer from frequent infections and symptoms. Clinical trials are available to patients with persistent symptoms.